![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
20
Jrh Biosciences Lenexa Us, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Foetal Bovine Serum, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2000-128 - Rev 00
This TSE Type CEP, issued on August 02, 2005, remains in force until September 18, 2006, ensuring its reliability within the pharmaceutical industry.